Sensitivity of quantitative metrics derived from DCE MRI and a pharmacokinetic model to image quality and acquisition parameters.
暂无分享,去创建一个
Daniel Normolle | Yue Cao | Diana Li | Zhou Shen | Yue Cao | D. Normolle | Zhou Shen | D. Li
[1] Lian Li,et al. Patlak plots of Gd‐DTPA MRI data yield blood–brain transfer constants concordant with those of 14C‐sucrose in areas of blood–brain opening , 2003, Magnetic resonance in medicine.
[2] Avraham Eisbruch,et al. Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study. , 2008, International journal of radiation oncology, biology, physics.
[3] Hai-Ling Margaret Cheng,et al. Investigation and optimization of parameter accuracy in dynamic contrast‐enhanced MRI , 2008, Journal of magnetic resonance imaging : JMRI.
[4] A. Padhani,et al. Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis , 2002, NMR in biomedicine.
[5] A. Padhani,et al. Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Aytekin Oto,et al. Reproducibility assessment of a multiple reference tissue method for quantitative dynamic contrast enhanced–MRI analysis , 2009, Magnetic resonance in medicine.
[7] H. Buchtel,et al. Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Biomarker for Prediction of Radiation-Induced Neurocognitive Dysfunction , 2009, Clinical Cancer Research.
[8] A. Padhani,et al. Reproducibility of quantitative dynamic MRI of normal human tissues , 2002, NMR in biomedicine.
[9] Laurent Hermoye,et al. Inflow correction of hepatic perfusion measurements using T1‐weighted, fast gradient‐echo, contrast‐enhanced MRI , 2004, Magnetic resonance in medicine.
[10] P. Wen,et al. A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients. , 2009, Cancer research.
[11] Mohammad Haris,et al. Improved bolus arrival time and arterial input function estimation for tracer kinetic analysis in DCE‐MRI , 2009, Journal of magnetic resonance imaging : JMRI.
[12] R. Herbst,et al. Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] D. Gadian,et al. Delay and dispersion effects in dynamic susceptibility contrast MRI: Simulations using singular value decomposition , 2000, Magnetic resonance in medicine.
[14] B K Rutt,et al. Temporal sampling requirements for the tracer kinetics modeling of breast disease. , 1998, Magnetic resonance imaging.
[15] Yue Cao,et al. WE‐D‐T‐6C‐03: Development of Image Software Tools for Radiation Therapy Assessment , 2005 .
[16] Natal A W van Riel,et al. On the identifiability of pharmacokinetic parameters in dynamic contrast‐enhanced imaging , 2007, Magnetic resonance in medicine.
[17] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[18] A. Jackson,et al. Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma. , 2003, The British journal of radiology.